This bio-tech company is innovating Maine

Black Bear alumni, faculty, staff, and students are among Maine’s most productive innovators and entrepreneurs. This month’s edition of our “Innovators of UMaine” series showcases Neuright, a Maine-based biotech company co-founded by Kristy Townsend ‘02 Ph.D. (above right), and Magdalena Blaszkiewicz ‘19G, Ph.D. (center). The company is developing a medical device that will aid in the diagnosis of peripheral neuropathy, specifically the small-fiber neuropathy that can manifest through sensations such as pins-and-needles, numbness, and tingling. Peripheral neuropathy is common in patients with diabetes and those who are undergoing chemotherapy treatments, but the condition also occurs without obvious cause, and is stubbornly difficult to diagnose, Townsend and Blaszkiewicz say. The pair, working with collaborators at UMaine including Rosemary Smith, professor of electrical and chemical engineering (above left); Leonard Kass, associate professor of biological sciences; Nuri Emanetoglu, associate professor of electrical and computer engineering; and Ali Abedi,  professor of electrical and computer engineering, have developed a microneedle electrode array that’s designed to record nerve activity. The goal is to create a functional diagnostic tool for aging and diabetes-related small fiber neuropathy. Read more

Related Posts

Bar Harbor approves Jackson Lab’s $33M expansion for rare disease research

The Bar Harbor Planning Board has approved a plan by the Jackson Laboratory to build a 20,000-square-foot expansion to its Rare Disease Translational...

22 August 2024

Bigelow lab receives $7 million for algae research, business development

Researchers at Bigelow Laboratory for Ocean Sciences believe algae can make a big splash in the agricultural, aquaculture and pharmaceutical industries,...

21 August 2024

Should Maine create a public medical school? UMaine System will study the question

The University of Maine System said this week it will work with a national consultant to study the feasibility of launching the state’s...

21 August 2024